Initial Diagnosis of Erosive Esophagitis: A Case Study Approach for Primary Care CME/CE

Author Information and Disclosures

Release Date: June 30, 2008; Valid for credit through June 30, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 nursing contact hours (None of these credits is in the area of pharmacology)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Wyeth
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify predictors of complications of gastroesophageal reflux disease (GERD), including erosive esophagitis
  2. Evaluate diagnostic strategies for identifying GERD and erosive esophagitis in individual patients within the primary care setting
  3. Incorporate planning for appropriate referral of patients for endoscopy or other specialized gastrointestinal screening
Authors and Disclosures

Kenneth R. DeVault, MD
Disclosure: Kenneth R. DeVault, MD, has disclosed that he has received grants for clinical research from AstraZeneca and TAP Pharmaceutical Products Inc. Dr. DeVault has also disclosed that he has received grants for educational activities from AstraZeneca, TAP Pharmaceutical Products Inc., and Santarus, Inc., and has served as an advisor or consultant to AstraZeneca, Altana Pharma, Ethicon, TAP Pharmaceutical Products Inc., and Santarus, Inc.


Jennifer Brown, PhD
Disclosure: Jennifer Brown, PhD, has disclosed no relevant financial relationships.


Anne E. Zitron, PhD
Disclosure: Anne E. Zitron, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.